Cited by 1,043Neurological diseases and metabolismParkinson's Disease Mechanisms and TreatmentsTrace Elements in Health

The DOI matches its Crossref record.

ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA

DEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E, LEES, A. J., JENNER, P., MARSDEN, C. D.·1991·Brain

DOI 10.1093/brain/114.4.1953

Open this paper in CoChat — free account

Abstract

Levels of iron, copper, zinc and manganese were measured by inductively coupled plasma spectroscopy in frozen postmortem brain tissue from patients with Parkinson's disease (PD), progressive supranuclear palsy (PSP), multiple system atrophy with strionigral degeneration (MSA), and Huntington's disease (HD) compared with control subjects. Total iron levels were found to be elevated in the areas of basal ganglia showing pathological change in these disorders. In particular, total iron content was increased in substantia nigra in PD, PSP and MSA, but not in HD. Total iron levels in the striatum (putamen and/or caudate nucleus) were increased in PSP, MSA and HD but not in PD. Total iron levels were decreased in the globus pallidus in PD. There were no consistent alterations of manganese levels in basal ganglia structures in any of the diseases studied. Copper levels were decreased in the substantia nigra in PD, and in the cerebellum in PSP, and were elevated in the putamen and possibly substantia nigra in HD. Zinc levels were only increased in PD, in substantia nigra and in caudate nucleus and lateral putamen. Levels of the iron binding protein ferritin were measured in the same patient groups using a radio-immunoassay technique. Increased iron levels in basal ganglia were generally associated with normal or elevated levels of ferritin immunoreactivity, for example, the substantia nigra in PSP and possibly MSA, and in putamen in MSA. The exception was PD where there was a generalized reduction in brain ferritin immunoreactivity, even in the substantia nigra. An increase in total iron content appears to be a response to neurodegeneration in affected basal ganglia regions in a number of movement disorders. However, only in PD was there an increased total iron level, decreased ferritin content, decreased copper content, and an increased zinc concentration in substantia nigra. These findings suggest an alteration of iron handling in the substantia nigra in PD. Depending on the form in which the excess iron load exists in nigra in PD, it may contribute to the neurodegenerative process.

Integrity signals

Registry

Crossref · 10.1093/brain/114.4.1953

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 801–900 of 1,000

An organic hydrogel film with micron-sized pillar array for real-time and indicator-free detection of Zn2+
Chao, Y., Huang, Y.-S., Wang, H.-P., et al. (2011) · Organic Electronics · doi:10.1016/j.orgel.2011.07.001 · Cited by 8
Determination of malondialdehyde in rat brain by capillary zone electrophoresis
Olsson, J. C., Karlberg, B., Kristensson, K., et al. (1998) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(97)00600-2 · Cited by 8
Role of Selenium, Iron, Copper, and Zinc in Parkinsonism
Qureshi, G. A., Syed, S. A., & Parvez, S. H. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50171-x · Cited by 8
Oxidative stress, brain iron and neurodegeneration. Basic principles
Gutteridge, J. M. C., & Halliwell, B. B. (1996) · Elsevier eBooks · doi:10.1016/b978-012525445-8/50003-5 · Cited by 8
Ligand Design to Target and Modulate Metal–Protein Interactions in Neurodegenerative Diseases
Beck, M. W., Pithadia, A. S., DeToma, A. S., Korshavn, K. J., & Lim, M. H. (2014) · Wiley eBooks · doi:10.1002/9781118697191.ch10 · Cited by 8
Nuclear microscopic investigations into the elemental changes in the substantia nigra of unilaterally MPTP-lesioned Parkinsonian monkeys
Thong, P. S. P., He, Y., Lee, T., & Watt, F. (1997) · Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms · doi:10.1016/s0168-583x(97)00239-5 · Cited by 8
How to accurately quantify brain magnetic susceptibility in the context of Parkinson's disease: Validation on phantoms and healthy volunteers at 1.5 and 3 T
Hervouin, A., Bézy‐Wendling, J., & Noury, F. (2024) · NMR in Biomedicine · doi:10.1002/nbm.5182 · Cited by 7
Potential separation of multiple system atrophy and Parkinson’s disease by susceptibility-derived components
Yan, S., Lu, J., Duan, B., et al. (2025) · NeuroImage · doi:10.1016/j.neuroimage.2025.121241 · Cited by 8
Metallomic analysis of brain tissues distinguishes between cases of dementia with Lewy bodies, Alzheimer’s disease, and Parkinson’s disease dementia
Scholefield, M., Church, S. J., Xu, J., & Cooper, G. J. S. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1412356 · Cited by 7
Functional Effects of a Neuromelanin Analogue on Dopaminergic Neurons in 3D Cell Culture
Collins, W., Rouleau, N., Bonzanni, M., Kapner, K. S., Jeremiah, A., Du, C., Pothos, E. N., & Kaplan, D. L. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00976 · Cited by 7
Deep grey matter quantitative susceptibility mapping from small spatial coverages using deep learning
Zhu, X., Gao, Y., Liu, F., Crozier‬, ‪., & Sun, H. (2021) · Zeitschrift für Medizinische Physik · doi:10.1016/j.zemedi.2021.06.004 · Cited by 7
Alterações de neuroimagem no parkinsonismo: estudo de cinco casos
da Costa, M. D. D. L., Gonçalves, L. R., Barbosa, E. R., et al. (2003) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2003000300011 · Cited by 7
Antioxidants as Therapy for Parkinson's Disease
Shults, C. W. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.694 · Cited by 7
Multiple system atrophy
Oertel, W. H., & Bandmann, O. (1999) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6360-3_9 · Cited by 7
Parkinson’s Disease
Burke, R. E. (1999) · Humana Press eBooks · doi:10.1007/978-1-4612-1602-5_22 · Cited by 12
Abnormal iron metabolism in the zona incerta in Parkinson’s disease mice
Xiu, M., Liu, Y., Wang, Z., Zhang, J., Shi, Y., Xie, J., & Shi, L. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-02913-3 · Cited by 6
Divalent and Trivalent Metallic Ions Differentially Affect Alpha-Synuclein Aggregation
Graves, N. J., Jaafar, A. K., Gambin, Y., & Sierecki, E. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00160 · Cited by 6
Association between Body Iron Status and Cognitive Task Performance in a Nationally Representative Sample of Older Adults
Peng, J., Liu, B., Tan, W., Hu, S., Li, B., Zhou, J., Xu, G., Sun, Y., Snetselaar, L. G., Wallace, R. B., et al. (2024) · Aging and Disease · doi:10.14336/ad.2019.0064 · Cited by 6
Ferritin as a biomarker of aging: geroprotective peptides of standardized human placental hydrolysate. A review
Громова, О. А., Torshin, I. Y., & Chuchalin, A. G. (2024) · Terapevticheskii arkhiv · doi:10.26442/00403660.2024.08.202811 · Cited by 6
Impaired Mitochondrial Function and Ubiquitin Proteasome System Activate α-Synuclein Aggregation in Zinc-Induced Neurotoxicity: Effect of Antioxidants
Singh, G., Mittra, N., & Singh, C. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02293-5 · Cited by 7
Neurotoxicity of copper and copper nanoparticles
Joshi, A., Farber, K., & Scheiber, I. F. (2021) · Advances in neurotoxicology · doi:10.1016/bs.ant.2020.11.001 · Cited by 6
Fundamental Neurochemistry Review: Copper availability as a potential therapeutic target in progressive supranuclear palsy: Insight from other neurodegenerative diseases
Billings, J. L., Hilton, J. B. W., Liddell, J. R., Hare, D. J., & Crouch, P. J. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15978 · Cited by 7
Investigation of iron’s neurotoxicity during cerebral maturation in the neonatal rat model of haemolysis
Akar, E., Ünalp, A., Dınız, G., et al. (2015) · Folia Neuropathologica · doi:10.5114/fn.2015.54623 · Cited by 6
Recent developments in meta-benziporphodimethene: A new porphyrin analogue
Ahluwalia, D., Kumar, A., & Warkar, S. G. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.129672 · Cited by 6
Brain Anatomy in Latino Farmworkers Exposed to Pesticides and Nicotine
Laurienti, P. J., Burdette, J. H., Talton, J. W., Pope, C., Summers, P., Walker, F. O., Quandt, S. A., Lyday, R. G., Chen, H., Howard, T. D., et al. (2016) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000000712 · Cited by 6
T2* Relaxometry in Patients with Parkinson’s Disease
Egger, K. E., Amtage, F., Yang, S., et al. (2016) · Clinical Neuroradiology · doi:10.1007/s00062-016-0523-2 · Cited by 6
Regulation of Neuroactive Metals by the Choroid Plexus
Li, G. J., & Zheng, W. (2005) · CRC Press eBooks · doi:10.1201/9781420023404.ch9 · Cited by 7
Dopamine mediated iron release from ferritin is enhanced at higher temperatures: Possible implications for fever-induced Parkinson's disease
Babincová, M., & Babinec, P. (2005) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2005.02.029 · Cited by 5
Oxidative stress in neurobiology: An important role for iron
Gutteridge, J. M. C. (1995) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7337-6_27 · Cited by 6
Multiple system atrophy
Geser, F., Colosimo, C., & Wenning, G. K. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.044 · Cited by 9
Intranigral Iron Infusion as a Model for Parkinson’s Disease
Arendash, G. W., Sengstock, G. J., Olanow, C. W., Barone, S., & Dunn, A. J. (1994) · Springer eBooks · doi:10.1007/978-1-4899-1447-7_7 · Cited by 6
Single-cell transcriptomic and neuropathologic analysis reveals dysregulation of the integrated stress response in progressive supranuclear palsyPreprint
Whitney, K. R., Song, W., Sharma, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.17.567587 · Cited by 6
Phenotypic characterization of an Atp13a2 knockout rat model of Parkinson’s disease
Kinet, R., Sikora, J., Arotçarena, M.-L., Decourt, M., Balado, É., Doudnikoff, É., Bohic, S., Vesnaver, M., Lovisotto, A., Thiolat, M.-L., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01171-0 · Cited by 6
Revisiting the alpha-synuclein paradox in melanoma-Parkinson’s disease connection: more than a tale of two cell fates
Aiello, J., Zamarato, R., Moscheni, C., Perrotta, C., Clerici, M., Trabattoni, D., Biasin, M., & Limanaqi, F. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05985-2 · Cited by 5
Ferroptosis in microglial activation: a systematic review and multidata comparison
Pesämaa, I., Koutarapu, S., Zetterberg, H., & Fruhwürth, S. (2026) · Brain Communications · doi:10.1093/braincomms/fcag109 · Cited by 6
Neuroimaging Biomarkers in Parkinson’s Disease
Holmes, S. E., & Tinaz, S. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-69491-2_21 · Cited by 5
Ferroptosis in neurodegenerative diseases: mechanisms and therapeutic potential of stem cell derivatives
Zhang, T., Zhang, Y., Xie, J., Lu, D., Wang, L., Zhao, S., Zhou, J., Cheng, Y., Kou, T., Wang, J., et al. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1577382 · Cited by 7
Gradients of Nigrostriatal Iron Deposition in Healthy Aging and Synucleinopathies
Wen, J., Guo, T., Duanmu, X., Wu, C., Wu, H., Zhou, C., Zheng, Q., Yuan, W., Qin, J., Zhu, Z., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70359 · Cited by 6
The role of astrocytes in human Huntington's disease pathology
Al‐Dalahmah, O., & Goldman, J. E. (2025) · Journal of Huntington s Disease · doi:10.1177/18796397251344173 · Cited by 6
Zinc and Neurodegenerative Disorders
Afolabi, O. B., Balogun, B. D., Oloyede, O. I., & Akinyemi, A. J. (2018) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-5225-5282-6.ch008 · Cited by 6
The role of d-block metal ions in neurodegenerative diseases
Posadas, Y., López-Guerrero, V. E., Arcos‐López, T., Sayler, R. I., Sánchez‐López, C., Segovia, J., Perez‐Cruz, C., & Quintanar, L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823144-9.00115-1 · Cited by 5
Pharmacological Prolyl Hydroxylase Domain Inhibition as a Therapeutic Target for Parkinson’s Disease
Rajagopalan, S., Chinta, S. J., & Andersen, J. K. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660131 · Cited by 5
Effects of a Direct Injection of Liposoluble Iron into Rat Striatum. Importance of the Rate of Iron Delivery to Cells
Demougeot, C., Méthy, D., Prigent‐Tessier, A., et al. (2002) · Free Radical Research · doi:10.1080/1071576021000033095 · Cited by 5
1.116 TRACE METALS IN PATIENTS WITH PARKINSON'S DISEASE: A MULTI-CENTER CASE-CONTROL STUDY IN NIGERIAN PATIENTS
Ogunrin, O. A., Sanya, E., Komolafe, M. A., et al. (2011) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70230-9 · Cited by 5
Iron in typical and atypical parkinsonism – Mössbauer spectroscopy and MRI studies
Kuliński, R., Bauminger, E. R., Friedman, A., et al. (2016) · Hyperfine Interactions · doi:10.1007/s10751-016-1234-4 · Cited by 5
Health effects of manganese exposures for welders in Qingdao City, China
Zhang, H., Xu, C., Wang, H., et al. (2016) · International Journal of Occupational Medicine and Environmental Health · doi:10.13075/ijomeh.1896.00694 · Cited by 5
Monte Carlo simulations of elemental imaging using the neutron‐associated particle technique
Abel, M. R., & Nie, L. H. (2018) · Medical Physics · doi:10.1002/mp.12797 · Cited by 5
Curcumin Derivatives as Metal-Chelating Agents: Implications for Potential Therapeutic Agents for Neurological Disorders
Ferrari, É. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815461-8.00015-3 · Cited by 5
Essential Metals in the Brain and the Application of Laser Ablation-Inductively Coupled Plasma-Mass Spectrometry for their Detection
Folarin, O. R., Olopade, F. E., & Olopade, J. O. (2021) · Nigerian Journal of Physiological Sciences · doi:10.54548/njps.v36i2.1 · Cited by 5
Cellular toxicity of zinc can be attenuated by sodium hydrogen sulfide in neuronal SH-SY5Y cell
Lee, S. R. (2018) · Molecular & Cellular Toxicology · doi:10.1007/s13273-018-0047-8 · Cited by 5
Synthesis, physicochemical characterization and neuroprotective evaluation of novel 1-hydroxypyrazin-2(1 H )-one iron chelators in an in vitro cell model of Parkinson's disease
Lewis, F. W., Bird, K., Navarro, J.-P., Fallah, R. E., Brandel, J., Hubscher‐Bruder, V., Tsatsanis, A., Duce, J. A., Tétard, D., Bourne, S., et al. (2022) · Dalton Transactions · doi:10.1039/d1dt02604f · Cited by 5
Clinical Spectrum and Pathological Features of Multiple System Atrophy
Colosimo, C., Geser, F., & Wenning, G. K. (2005) · Elsevier eBooks · doi:10.1016/b978-012088382-0/50049-9 · Cited by 6
Subchronic Administration of Haloperidol Influences the Functional Deficits of Postnatal Iron Administration in Mice
Fredriksson, A., & Archer, T. (2006) · Neurotoxicity Research · doi:10.1007/bf03033321 · Cited by 5
Correlation of subthalamic nuclei T2 relaxation times with neuropsychological symptoms in patients with Parkinson's disease
Watanabe, S., Suenaga, K., Yamamoto, A., et al. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.11.018 · Cited by 5
Innovative MRT-Verfahren bei idiopathischem Parkinson-Syndrom
Baudrexel, S., Klein, J. C., Deichmann, R., et al. (2010) · Der Nervenarzt · doi:10.1007/s00115-010-3023-7 · Cited by 5
Copper in Brain and Neurodegeneration
Liddell, J. R., Bush, A. I., & White, A. R. (2004) · Encyclopedia of Inorganic and Bioinorganic Chemistry · doi:10.1002/9781119951438.eibc2143 · Cited by 5
Modifiers of Protein Aggregation—From Nonspecific to Specific Interactions
Levy‐Sakin, M., Scherzer‐Attali, R., & Gazit, E. (2012) · Wiley eBooks · doi:10.1002/9781118183373.ch15 · Cited by 5
Health risks of welding fumes: A review to investigate the relationship between oxidative stress levels and trace metals in body fluids of welders
Zeverdegani, S. K., Mohammadi, F., Mohammadalipour, A., Hashemnia, M., & Mohebian, Z. (2024) · Environmental Health Engineering and Management · doi:10.34172/ehem.2024.24 · Cited by 4
Multimodal MRI biomarkers optimize differentiation between progressive supranuclear palsy and Parkinson's disease
Chen, T., Gong, T., Chen, Y., Yang, A., Zhao, C., Sun, Z., Zhao, Y., Zhou, L., Chen, W., Liu, Y., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107076 · Cited by 4
Simultaneous Brain Iron and α-Synuclein Detection in Patients with Synucleinopathies via Quantitative Susceptibility Mapping MRI
Li, Z., Zhu, Z., Lv, S., Guan, X., Zhang, Y., Liu, C., Li, D., & Wei, H. (2026) · Radiology · doi:10.1148/radiol.251189 · Cited by 5
Translational Research in Neurology and Neuroscience 2010-2011
Rosenberg, R. N. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.247 · Cited by 4
Spatiotemporal neurodegeneration of the substantia nigra and its connecting cortex and subcortex in Parkinson's disease
Wen, J., Duanmu, X., Tan, S., Wu, C., Peng, X., Qin, J., Guo, T., Wang, S., Wu, H., Zhou, C., et al. (2024) · European Journal of Neurology · doi:10.1111/ene.16546 · Cited by 4
Cerebral Venous thrombosis, Neutropenia and iron-deficiency Anemia in Huntington Disease
Tabibian, F., Adibi, I., Ardestani, P. E., Tabibian, E., Akbaripour, S., & Bürk, K. (2021) · Neurodegenerative Disease Management · doi:10.2217/nmt-2020-0045 · Cited by 3
Postencephalitic Parkinsonism: Unique Pathological and Clinical Features—Preliminary Data
Strobel, S., Sian‐Hülsmann, J., Tappe, D., Jellinger, K. A., Riederer, P. F., & Monoranu, C. (2024) · Cells · doi:10.3390/cells13181511 · Cited by 5
Decreased spinal cord motor neuron numbers in mice depleted of central nervous system copper
Liddell, J. R., Hilton, J. B. W., Wang, Y., et al. (2024) · Metallomics · doi:10.1093/mtomcs/mfae036 · Cited by 4
Copper Dyshomeostasis and Diabetic Complications: Chelation Strategies for Management
Subramaniam, J., Aditi, A., Arumugam, K., Sri, S., Rajesh, B. S., & Ramkumar, K. M. (2024) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575308206240911104945 · Cited by 4
Spatial single-cell multiomics reveals peripheral immune dysfunction in Parkinson’s and inflammatory bowel disease
Bolen, M. L., Buendia, M., Shi, J., Staley, H. A., Kachergus, J. M., Efron, P. A., Park, G., Nagpal, R., Alvarez, S. D., Xue, Q., et al. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-025-01199-2 · Cited by 6
Toxic causes of parkinsonism
Lev, N., Melamed, E., & Offen, D. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)84050-4 · Cited by 5
Blood‚ÄìCSF Barrier in Iron Regulation and Manganese-Induced Parkinsonism
Zheng, W. (2005) · CRC Press eBooks · doi:10.1201/9781420023404.ch17 · Cited by 4
Neuroprotektive Therapien bei idiopathischen, genetischen und atypischen Parkinson-Syndromen mit α-Synuklein – Pathologie
Levin, J., Nübling, G., Giese, A., Janzen, A., & Oertel, W. H. (2021) · Der Nervenarzt · doi:10.1007/s00115-021-01220-y · Cited by 4
Super-resolution QSM in little or no additional time for imaging (NATIve) using 2D EPI imaging in 3 orthogonal planes
Bachrátá, B., Bollmann, S., Jin, J., Tourell, M. C., Dal‐Bianco, A., Trattnig, S., Barth, M., Ropele, S., Enzinger, C., & Robinson, S. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.120419 · Cited by 4
Towards Small Molecules as Therapies for Alzheimer’s Disease and Other Neurodegenerative Disorders
Aziz, O., Bürli, R. W., Fischer, D. F., Frearson, J. A., & Wall, M. D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-803959-5.50004-0 · Cited by 5
Neurological Disorders Associated with Iron Misdistribution: The Therapeutic Potential of Siderophores
Kakhlon, O., Breuer, B., Münnich, A., & Cabantchik, Z. I. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-514-9_11 · Cited by 4
Maladie de Parkinson: m�canismes physiopathologiques et effets du pirib�dil
Jenner, P. G. (1993) · Journal of Neurology · doi:10.1007/bf00879099 · Cited by 4
Self-citation
The phase value of putamen measured by susceptibility weighted images in Parkinson’s disease and in other forms of Parkinsonism: a correlation study with F18 FP-CIT PET
Kwon, G. H., Jang, J., Choi, H. S., et al. (2015) · Acta Radiologica · doi:10.1177/0284185115604515 · Cited by 4
Blood Vessels And Neurodegeneration In Parkinson’s Disease
Barcia, C., Sánchez-Bahíllo, A., Bautista‐Hernández, V., Navarro-Ruiz, J., Fernández‐Villalba, E., Faucheux, B. A., Hirsch, É. C., & Herrero, M. T. (2002) · Advances in behavioral biology · doi:10.1007/978-1-4615-0715-4_34 · Cited by 4
Brain Iron and other Trace Metals in Neurodegenerative Diseases
Gerlach, M., Youdim, M. B. H., & Riederer, P. F. (2000) · Springer eBooks · doi:10.1007/978-1-4615-1269-1_25 · Cited by 4
Postnatal iron-induced motor behaviour alterations following chronic neuroleptic administration in mice
Fredriksson, A., Eriksson, P., & Archer, T. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0307-3 · Cited by 4
Letter to the editor
Fénelon, G., Percheron, G., Jankovic, J. J., Gerlach, M., Double, K. L., Riederer, P. F., Hirsch, É. C., Jellinger, K. A., Jenner, P. G., TRAUTWEIN, A. X., et al. (1997) · Movement Disorders · doi:10.1002/mds.870120224 · Cited by 4
Self-citation
Multiple System Atrophy: Clinical, Genetics, and Neuropathology
Schottlaender, L., Sailer, A., Ahmed, Z., Dickson, D. W., Houlden, H., & Ross, O. A. (2017) · Neurodegeneration · doi:10.1002/9781118661895.ch7 · Cited by 4
Leveraging Proteomics to Explore the Molecular Mechanisms of Primary Tauopathies
Nementzik, L. R., Kavanagh, T., Genoud, S., & Drummond, E. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70270 · Cited by 3
Exploring the Relationship between Parkinson’s Disease and Restless Legs Syndrome
López‐Jiménez, A., Anguizola, D., Aragón, A. G., Moncada, B., de Noël, A. C. A., & Garcı́a-Borreguero, D. (2025) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2025.05.001 · Cited by 3
Contribution of neuroimaging in the diagnosis of brain disorders: Recent findings and future applications
Jeong, H. S., & Chung, Y. (2016) · International Journal of Imaging Systems and Technology · doi:10.1002/ima.22167 · Cited by 3
Magnetic resonance imaging modalities aid in the differential diagnosis of atypical parkinsonian syndromes
Tinaz, S. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1082060 · Cited by 3
Multiple Copper Ions Bind to and Promote the Oligomerization of Huntingtin Protein with Nonpathological Repeat Expansions
Neupane, D., Santos-Fernandez, M., Fernandez-Lima, F. A., & Meier, K. K. (2025) · Biochemistry · doi:10.1021/acs.biochem.5c00012 · Cited by 3
Zinc-Dependent Modulation of Dopamine Release and Uptake Is Altered in Parkinson’s Disease Model Zebrafish
Hettiarachchi, P., Shigemoto, A. K., Hickey, E. E., Burdette, S. C., & Johnson, M. A. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00864 · Cited by 4
The Effects of Trace Element Deficiencies on Neurological Disease and Treatment with Trace Element Support
Bayır, A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411462-3.00016-3 · Cited by 3
The Role of Ceruloplasmin in Neurodegeneration in Parkinson’s Disease
Gürer, R., Aydın, Ş., Gökçe, D., Ayaz, T., & Işık, N. (2016) · Turkish Journal Of Neurology · doi:10.4274/tnd.58751 · Cited by 3
Diagnosis of Parkinson’s Disease—Transcranial Sonography in Relation to MRI
Niehaus, L., & Boelmans, K. (2010) · International review of neurobiology · doi:10.1016/s0074-7742(10)90005-6 · Cited by 3
Iron Deficiency and Excess in the Brain: Implications for Cognitive Impairment and Neurodegeneration
Youdim, M. B. H., Gerlach, M., & Riederer, P. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-462-9_6 · Cited by 4
Alteration of Striatal Tetrahydrobiopterin in Iron-Induced Unilateral Model of Parkinson's Disease
Aryal, B., Lee, J.-K., Kim, H. R., & Kim, H. (2014) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2014.18.2.129 · Cited by 3
Potassium channels are involved in zinc‐induced apoptosis in MES23.5 cells
Shi, L., Song, N., Jiang, H. F., et al. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21854 · Cited by 3
Delay Period Activity of the Substantia Nigra during Proactive Control of Response Selection as Determined by a Novel fMRI Localization Method
Yoon, J. H., Larson, P., Grandelis, A., La, C., Cui, E., Carter, C. S., & Minzenberg, M. (2014) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_00775 · Cited by 3
Expression of RNAs Coding for Metal Transporters in Blood of Patients with Huntington’s Disease
Szeliga, M., Różycka, A., Jędrak, P., Barańska, S., Janik, P., Jamrozik, Z., & Albrecht, J. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1737-4 · Cited by 3
Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in Mice
Fredriksson, A., & Archer, T. (2006) · Neurotoxicity Research · doi:10.1007/bf03033241 · Cited by 3
Oxidative Stress with Emphasis on the Role of LAMMA in Parkinson’s Disease
Good, P. F., Perl, D. P., & Olanow, C. W. (1997) · Springer eBooks · doi:10.1007/978-1-4899-0197-2_14 · Cited by 3
Serotonin Binding Proteins: AnIn VitroModel System for Monoamine‐related Neurotoxicitya
Vauquelin, G., Jiménez-Del-Río, M., & Pardo, C. V. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21830.x · Cited by 3
Metallothionein in oxidative stress of Parkinson’s disease
Ebadi, M., Hiramatsu, M., Kumari, M. V. R., Hao, R., & Pfeiffer, R. F. (1999) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8847-9_49 · Cited by 3
Copper, Ceruloplasmin, Zinc, and Manganese Levels in Brain and Biological Fluids from Parkinson’s Disease Patients: Systematic Review and Meta-Analysis
Jiménez-Jiménez, F. J., Alonso‐Navarro, H., García‐Martín, E., Martín-Gómez, M. Á., Salgado-Cámara, P., Cárcamo-Fonfría, A., Arroyo-Solera, M., & Agúndez, J. A. G. (2026) · Cells · doi:10.3390/cells15030288 · Cited by 4
Quantitative imaging of iron dysregulation in multiple system atrophy
Trujillo, P., Hett, K., Cooper, A., et al. (2026) · NeuroImage · doi:10.1016/j.neuroimage.2026.121965 · Cited by 2

Authors: DEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E., LEES, A. J., JENNER, P., & MARSDEN, C. D.
Affiliations: King's College London (GB)
Inserm (FR)
Parkinson's UK (GB)
Corresponding author: JENNER, P.
ORCID: DEXTER, D. T.
DANIEL, S. E
LEES, A. J.
JENNER, P.
Venue: Brain
Publisher: Oxford University Press (OUP)
Published: 1991
Volume: 114
Issue: 4
Pages: 1953-1975
ISSN: 0006-8950 (ISSN-L)
1460-2156
DOI: 10.1093/brain/114.4.1953
OpenAlex: W2123913108
Cited by: 1,043
References: 0
Citations by year: 2026: 18 · 2025: 29 · 2024: 47 · 2023: 28 · 2022: 37 · 2021: 43 · 2020: 36 · 2019: 38 · 2018: 30 · 2017: 45 · 2016: 56 · 2015: 45 · 2014: 41 · 2013: 44 · 2012: 32
FWCI: 12.57
Type: journal article
Language: en
Open access: closed
Locations: Brain (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Funders: Royal Society
Topics: Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
Keywords: Parkinson's disease, progressive supranuclear palsy, multiple system atrophy, Huntington's disease, basal ganglia, iron, ferritin, copper, zinc, manganese, substantia nigra, striatum, globus pallidus, neurodegeneration, trace metals, iron overload
MeSH terms: Aging, Atrophy, Basal Ganglia Diseases, Brain, Brain Diseases, Ferritins, Humans, Huntington Disease, Iron, Metals, Parkinson Disease, Radioimmunoassay, Reference Values, Supranuclear Palsy, Progressive, Trace Elements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks